vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Noble Corp plc (NE). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $764.4M, roughly 1.3× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs 7.7%, a 3.6% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -17.6%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $35.4M). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
ATR vs NE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $962.7M | $764.4M |
| Net Profit | $74.3M | $86.6M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 5.6% |
| Net Margin | 7.7% | 11.3% |
| Revenue YoY | 13.5% | -17.6% |
| Net Profit YoY | -26.4% | -10.4% |
| EPS (diluted) | $1.13 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $764.4M | ||
| Q3 25 | $961.1M | $798.0M | ||
| Q2 25 | $966.0M | $848.7M | ||
| Q1 25 | $887.3M | $874.5M | ||
| Q4 24 | $848.1M | $927.3M | ||
| Q3 24 | $909.3M | $800.5M | ||
| Q2 24 | $910.1M | $692.8M | ||
| Q1 24 | $915.4M | $637.1M |
| Q4 25 | $74.3M | $86.6M | ||
| Q3 25 | $127.9M | $-21.1M | ||
| Q2 25 | $111.7M | $42.9M | ||
| Q1 25 | $78.8M | $108.3M | ||
| Q4 24 | $100.9M | $96.6M | ||
| Q3 24 | $100.0M | $61.2M | ||
| Q2 24 | $90.5M | $195.0M | ||
| Q1 24 | $83.1M | $95.5M |
| Q4 25 | 11.0% | 5.6% | ||
| Q3 25 | 14.2% | 6.3% | ||
| Q2 25 | 14.9% | 15.9% | ||
| Q1 25 | 12.8% | 21.4% | ||
| Q4 24 | 14.2% | 18.4% | ||
| Q3 24 | 15.2% | 14.4% | ||
| Q2 24 | 13.8% | 30.3% | ||
| Q1 24 | 12.2% | 16.9% |
| Q4 25 | 7.7% | 11.3% | ||
| Q3 25 | 13.3% | -2.6% | ||
| Q2 25 | 11.6% | 5.1% | ||
| Q1 25 | 8.9% | 12.4% | ||
| Q4 24 | 11.9% | 10.4% | ||
| Q3 24 | 11.0% | 7.6% | ||
| Q2 24 | 9.9% | 28.1% | ||
| Q1 24 | 9.1% | 15.0% |
| Q4 25 | $1.13 | $0.54 | ||
| Q3 25 | $1.92 | $-0.13 | ||
| Q2 25 | $1.67 | $0.27 | ||
| Q1 25 | $1.17 | $0.67 | ||
| Q4 24 | $1.48 | $0.56 | ||
| Q3 24 | $1.48 | $0.40 | ||
| Q2 24 | $1.34 | $1.34 | ||
| Q1 24 | $1.23 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $471.4M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $4.5B |
| Total Assets | $5.3B | $7.5B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $471.4M | ||
| Q3 25 | $264.8M | $477.9M | ||
| Q2 25 | $169.8M | $338.2M | ||
| Q1 25 | $136.8M | $303.8M | ||
| Q4 24 | $226.2M | $247.3M | ||
| Q3 24 | $327.9M | $391.9M | ||
| Q2 24 | $223.9M | $162.9M | ||
| Q1 24 | $201.1M | $212.5M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $4.5B | ||
| Q3 25 | $2.8B | $4.5B | ||
| Q2 25 | $2.7B | $4.6B | ||
| Q1 25 | $2.5B | $4.7B | ||
| Q4 24 | $2.5B | $4.7B | ||
| Q3 24 | $2.5B | $4.7B | ||
| Q2 24 | $2.4B | $4.0B | ||
| Q1 24 | $2.3B | $3.9B |
| Q4 25 | $5.3B | $7.5B | ||
| Q3 25 | $5.1B | $7.6B | ||
| Q2 25 | $4.9B | $7.7B | ||
| Q1 25 | $4.5B | $7.9B | ||
| Q4 24 | $4.4B | $8.0B | ||
| Q3 24 | $4.6B | $8.0B | ||
| Q2 24 | $4.5B | $5.6B | ||
| Q1 24 | $4.4B | $5.4B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $187.1M |
| Free Cash FlowOCF − Capex | $96.9M | $35.4M |
| FCF MarginFCF / Revenue | 10.1% | 4.6% |
| Capex IntensityCapex / Revenue | 9.0% | 19.9% |
| Cash ConversionOCF / Net Profit | 2.47× | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $432.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $187.1M | ||
| Q3 25 | $177.6M | $277.1M | ||
| Q2 25 | $126.0M | $216.4M | ||
| Q1 25 | $82.7M | $271.1M | ||
| Q4 24 | $178.2M | $136.2M | ||
| Q3 24 | $229.3M | $283.8M | ||
| Q2 24 | $143.6M | $106.8M | ||
| Q1 24 | $92.3M | $128.7M |
| Q4 25 | $96.9M | $35.4M | ||
| Q3 25 | $114.3M | $139.5M | ||
| Q2 25 | $62.5M | $99.8M | ||
| Q1 25 | $25.9M | $157.5M | ||
| Q4 24 | $112.2M | $-4.4M | ||
| Q3 24 | $162.7M | $156.8M | ||
| Q2 24 | $75.4M | $-34.3M | ||
| Q1 24 | $16.7M | $-37.9M |
| Q4 25 | 10.1% | 4.6% | ||
| Q3 25 | 11.9% | 17.5% | ||
| Q2 25 | 6.5% | 11.8% | ||
| Q1 25 | 2.9% | 18.0% | ||
| Q4 24 | 13.2% | -0.5% | ||
| Q3 24 | 17.9% | 19.6% | ||
| Q2 24 | 8.3% | -4.9% | ||
| Q1 24 | 1.8% | -6.0% |
| Q4 25 | 9.0% | 19.9% | ||
| Q3 25 | 6.6% | 17.3% | ||
| Q2 25 | 6.6% | 13.7% | ||
| Q1 25 | 6.4% | 13.0% | ||
| Q4 24 | 7.8% | 15.2% | ||
| Q3 24 | 7.3% | 15.9% | ||
| Q2 24 | 7.5% | 20.4% | ||
| Q1 24 | 8.3% | 26.2% |
| Q4 25 | 2.47× | 2.16× | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | 5.05× | ||
| Q1 25 | 1.05× | 2.50× | ||
| Q4 24 | 1.77× | 1.41× | ||
| Q3 24 | 2.29× | 4.64× | ||
| Q2 24 | 1.59× | 0.55× | ||
| Q1 24 | 1.11× | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |